IgA Nephropathy Market Size & Outlook 2025 to 2035

Future Market Insights

IgA Nephropathy Market

Key Insight

IgA nephropathy sales will expand through 2036, with primary IgA nephropathy at 81.0% of the disease type category and hospitals at 62.1% of end-user demand in 2026. The market was valued at USD 46.82 billion in 2025 and is forecast to record a 7.6% CAGR between 2026 and 2036.

June 16, 2025

Anurag Sharma

299 Pages

Cite this Report

IgA Nephropathy Market

https://www.futuremarketinsights.com/reports/iga-nephropathy-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

BlackRock
Novartis
Organon Group of Companies
The Vanguard Group
L'Oréal
Takeda Pharmaceutical Company Limited
Validus Pharmaceuticals LLC

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

IgA Nephropathy Market

Key Players

Similar Industry Reports